8-KMaterial Agreements

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Material Agreement (Oct 27, 2006)

Filed October 27, 2006For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on October 27, 2006, reporting a material definitive agreement related to the termination of employment for its Senior Vice President of Business Development, Vincent J. Miles, Ph.D. The agreement outlines a phased transition of Dr. Miles's employment, beginning with full-time service through December 31, 2006, followed by part-time service from January 1, 2007, until August 1, 2007, or an earlier termination. This filing is primarily administrative, detailing the terms of separation, compensation, and benefits continuation during this transition period.

Key Highlights

  • 1Alnylam Pharmaceuticals entered into a separation agreement with its Senior Vice President of Business Development, Dr. Vincent J. Miles.
  • 2Dr. Miles's employment will transition from full-time to part-time status.
  • 3Full-time employment is expected to continue until December 31, 2006.
  • 4Part-time employment is scheduled from January 1, 2007, to August 1, 2007.
  • 5Compensation includes continued base salary through December 31, 2006, and 50% of base salary thereafter until August 1, 2007.
  • 6The company will reimburse Dr. Miles for COBRA health insurance premium differences if his employment is terminated without cause before August 1, 2007.
  • 7Dr. Miles will receive a lump-sum cash payment based on his part-time employment duration, with provisions for termination without cause.

Frequently Asked Questions

The main purpose of this 8-K filing is to report a material definitive agreement regarding the separation of Dr. Vincent J. Miles, the Senior Vice President of Business Development, from Alnylam Pharmaceuticals.

Dr. Miles will remain employed full-time until December 31, 2006, and then transition to part-time employment until August 1, 2007. His compensation during the part-time period will be 50% of his base salary, with a lump-sum payment tied to his continued part-time service. The company will also reimburse him for COBRA health insurance costs under specific conditions.

The agreement involves continued salary payments and potential lump-sum payments to Dr. Miles, as well as reimbursement for COBRA insurance premiums. These represent an incremental cost to the company during the transition period.

This filing is an administrative report detailing a personnel separation agreement. It does not, on its own, provide information to suggest issues with the company's business development strategy. Such agreements are common during employee transitions.